Fig. 3From: [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety resultsPlot showing the temporal relationship of the median value of visual analogue score (VAS) of patients from baseline up to 16 weeks of post-[177Lu]Lu-DOTA-ZOL therapyBack to article page